PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

AHA Registry Analysis Links Cardiology Team Access to Anticoagulation Gaps

observationalregistry-analysisanticoagulationatrial-fibrillationsocial-determinantshealth-disparitiesmachine-learning Anticoagulation / Hematology

Background Information

Social factors affect anticoagulant prescriptions for atrial fibrillation.

Understanding social determinants of health (SDOH) can improve the prescription of oral anticoagulants (OAC) for patients with atrial fibrillation, potentially reducing stroke risk. Out of 68,628 eligible patients, 1,345 (2.0%) did not receive guideline-directed OAC. The absence of a cardiology team had the highest impact with an adjusted odds ratio of 3.72. The study highlights key SDOH affecting OAC prescriptions, emphasizing the need for addressing institutional barriers like the absence of a cardiology team. Social determinants significantly influence OAC prescription practices for atrial fibrillation, with institutional factors playing a critical role.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Osawa I, Shimada YJ

Citation: Osawa I, Shimada YJ Social Determinants of Guideline-Directed Oral Anticoagulation Prescription in Patients With Atrial Fibrillation Without Contraindications: Findings From the American Heart Association Get With the Guidelines-Atrial Fibrillation Registry. Journal of the American Heart Association. 2026;15(19):e050448. doi:10.1161/JAHA.126.050448

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.